Atea Pharmaceuticals investor relations material

Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapeutics for patients suffering from viral infections. The company's pipeline includes several product candidates. Some of these medications have been demonstrated to have antibacterial activity against various bacterial pathogens and anti-inflammatory effects in animal studies.